Asist dr Vladimir Milivojević, PhD

Asist. dr sci med. Vladimir Milivojević

Asist dr Vladimir Milivojević, PhD

Gastroenterologist - hepatologist

Gastroenterologist - hepatologist

Specific Professional Orientation:

Dr. Vladimir Milivojević is professionally oriented towards all aspects of clinical gastroenterology and hepatology. Dr. Milivojević particularly expresses interest in the areas of Helicobacter pylori infection, gastritis, peptic ulcer disease, gastroesophageal reflux disease, celiac disease, eosinophilic esophagitis, dyspepsia, irritable bowel syndrome (IBS), disorders of intestinal microbiota (dysbiosis), and the treatment of patients with abnormalities in liver function tests (elevated transaminases), issues related to metabolic syndrome, and liver function disorders. Additionally, he emphasizes the significance of nutrition in gastroenterology.

A field of exceptional interest for him is gastrointestinal endoscopy. In addition to diagnostic gastroscopy and colonoscopy, Dr. Milivojević performs interventional and therapeutic procedures, including the removal of polyps from the stomach, duodenum, and colon, as well as the execution of the most complex endoscopic ERCP (Endoscopic Retrograde Cholangiopancreatography) procedures in both diagnostic and therapeutic aspects.

 

Education:

  • 2019–2022: Faculty of Medicine, University of Belgrade – Clinical Assistant (appointment to position) in Internal Medicine
  • 2023: Faculty of Medicine, University of Belgrade – Doctorate in Medical Pharmacology
  • 2016: Faculty of Medicine, University of Belgrade – Specialization in Internal Medicine
  • 2014: Faculty of Medicine, University of Belgrade – Master’s Degree in the Digestive System
  • 2007: Faculty of Medicine, University of Belgrade – Undergraduate studies – Doctor of Medicine

 

Work:

  • Clinic for Gastroenterology and Hepatology, University Medical Center Serbia
  • Faculty of Medicine, University of Belgrade

 

Additional Scientific Activities:

Invited Lectures (International Conferences):

  1. European Congress of Young Gastroenterologists – Zagreb (Croatia), 2018.
  2. European “Bridging” Meeting in Gastroenterology – EAGEN, Warsaw (Poland), 2018.
  3. European Group for the Study of Helicobacter pylori and Microbiota – Kaunas (Lithuania), 2018.
  4. 4th International Meeting Alps – Adriatic – Danube & SAGH Conference – Portorož (Slovenia), 2019.
  5. Dilemmas and Controversies 3 – Bečići (Montenegro), 2021.
  6. Dilemmas and Controversies 6 – Herceg Novi (Montenegro), 2022.
  7. European Transition Meeting in Gastroenterology – EAGEN, Kaunas (Lithuania), 2022.
  8. European Study Group on Helicobacter and Microbiota – Antwerp (Belgium), 2023.

 

Awards and Recognitions:

  1. Award for the Best Poster Presentation, Third Serbian Gastroenterology Congress 2015. Assessment of the 28-day mortality rate in patients with acute-to-chronic liver failure.
  2. Co-author of a poster presentation – UEGW Barcelona 2015-Poster of Excellence – Values of erythropoietin in the acute phase of chronic liver failure – preliminary data.
  3. Recipient of the UEGW scholarship for the best abstract for the year 2022.
  4. Recipient of the UEGW project scholarship for developing countries in 2020, aiming to organize the Congress of Young Gastroenterologists of Serbia (not held due to the COVID-19 epidemic).
  5. Award for the Best Poster Presentation – Fifth Serbian Gastroenterology Congress 2023 – Genetic basis of Helicobacter pylori resistance to clarithromycin and fluoroquinolones.
  6. Recognition on the occasion of marking 100 years of the Faculty of Medicine, University of Belgrade, for outstanding contribution to the Faculty’s fight against COVID-19.

 

Training:

  • Trainee in endoscopy through a grant from the Association of Gastroenterological Endoscopy of Serbia – Scholarship Program ESGE/SSGE – Endoscopy Unit Zagreb, Hospital Rebro, September 2017.
  • Professional training in Rome, Gemelli Hospital, fecal microbiota transplantation program – Gemelli Hospital Rome, Italy, October 2017.
  • ALS License – Advanced Life Support Course Advantage, Belgrade, Serbia 2015.
  • Participant in several ESPEN (European Society for Clinical Nutrition and Metabolism) LLL courses on Parenteral and Enteral Nutrition – ESPEN, Dubrovnik 2015, Belgrade 2017, Aranđelovac 2018.
  • Participant in four summer school programs with practical endoscopic training in Prague organized by UEG (2012, 2013, 2014, and 2015).
  • Course in endotracheal intubation and central venous catheter placement, Faculty of Medicine, Belgrade.
  • Seminar participant in Paris; “Georges Pompidou” Hospital Paris – “Adult Hanging” 2011.
  • Student exchange during undergraduate studies at “San Martino” Hospital, Genoa, Italy, in the field of emergency medicine and surgery /2006/.

 

Memberships:

  • President of the Section for Nutrition, Microbiota, and Immunometabolism (SLD)
  • Member of the National Association for Clinical Nutrition of Serbia (NUPENS)
  • Member of the organizing committee of the congress Dilemmas and Controversies 1, Dilemmas and Controversies 2, Dilemmas and Controversies 3, Dilemmas and Controversies 4, Dilemmas and Controversies 5, Dilemmas and Controversies 6, Dilemmas and Controversies 7.
  • Member of the organizing committee of the “15th ACCN Course of Clinical Nutrition”
  • Member of the scientific committee of the Association of Young Gastroenterologists within the Association of Gastroenterologists of Serbia.
  • Member of the National Association of Gastroenterohepatologists and Nephrologists
  • Member of the Serbian Endoscopic Association – GEUS
  • Member of the European Gastroenterological Association (UEG)
  • Member of the European Society for Gastrointestinal Endoscopy (ESGE).
  • Member of the European Society for Clinical Nutrition and Metabolism ESPEN
  • Member of EAGEN (European Association for Gastroenterology and Endoscopy)

 

Bibliography:

Bibliography (10 most recent publications):

  1. Jonaitis P, Nyssen OP, Saracino IM, Fiorini G, Vaira D, Pérez-Aísa Á, Tepes B, Castro-Fernandez M, Pabón-Carrasco M, Keco-Huerga A, Voynovan I, Lucendo AJ, Lanas Á, Martínez-Domínguez SJ, Almajano EA, Rodrigo L, Vologzanina L, Brglez Jurecic N, Denkovski M, Bujanda L, Mahmudov U, Leja M, Lerang F, Babayeva G, Bordin DS, Gasbarrini A, Kupcinskas J, Gridnyev O, Rokkas T, Marcos-Pinto R, Phull PS, Smith SM, Tonkić A, Boltin D, Buzás GM, Šembera Š, Şimşek H, Matysiak-Budnik T, Milivojevic V, Marlicz W, Venerito M, Boyanova L, Doulberis M, Capelle LG, Cano-Català A, Moreira L, Mégraud F, O’Morain C, Gisbert JP, Jonaitis L; Hp-EuReg investigators. Comparison of the management of Helicobacter pylori infection between the older and younger European populations. Sci Rep. 2023 Oct 11;13(1):17235.
  2. Rankovic I, Milivojevic V. Critical illness associated hemostatic failure-diagnostic revival of the bleeding time test? The Egyptian Journal of Surgery. 42(4):825-826, October-December 2023.
  3. Nyssen, O.P.; Pratesi, P.; Spínola, M.A.; Jonaitis, L.; Pérez-Aísa, Á.; Vaira, D.; Saracino, I.M.; Pavoni, M.; Fiorini, G.; Tepes, B., Milivojevic, V….; et al. Analysis of Clinical Phenotypes through Machine Learning of First-Line H. pylori Treatment in Europe during the Period 2013–2022: Data from the European Registry on H. pylori Management (Hp-EuReg). Antibiotics 2023, 12, 1427.
  4. García-Morales, N.; Pérez-Aísa, Á.; Fiorini, G.; Tepes, B.; Castro-Fernández, M.; Lucendo, A.; Voynovan, I.; Bujanda, L.; Garre, A.; Rodrigo, L., Milivojevic, V….; et al. Helicobacter pylori Diagnostic Tests Used in Europe: Results of over 34,000 Patients from the European Registry on Helicobacter pylori Management. J. Clin. Med. 2023, 12, 4363.
  5. Milivojević, V.; Bogdanović, J.; Babić, I.; Todorović, N.; Ranković, I. Metabolic Associated Fatty Liver Disease (MAFLD) and COVID-19 Infection: An Independent Predictor of Poor Disease Outcome? Medicina 2023, 59, 1438.
  6. Bačić A, Milivojević V*, Petković I, Kekić D, Gajić I, Medić Brkić B, Popadić D, Milosavljević T, Rajilić-Stojanović M. In Search for Reasons behind Helicobacter pylori Eradication Failure-Assessment of the Antibiotics Resistance Rate and Co-Existence of Helicobacter pylori with Candida Species. J Fungi (Basel). 2023 Mar 7;9(3):328. *Shared authorship.
  7. Milivojevic V, Babic I, Kekic D, Rankovic I, Sagdati S, Panic N, Sekulic Spasic I, Krstic M, Milosavljevic T, Moreira L, Perez Nyssen O, Mégraud F, O’ Morain C, Gisbert J. Current trends in the management of Helicobacter pylori infection in Serbia: preliminary results from the European registry on H. pylori management (Hp-EuReg). Dig Dis. 2022 Dec 20.
  8. Burgos-Santamaría D, Nyssen OP, Gasbarrini A, Vaira D, Pérez-Aisa Á, Rodrigo L, Pellicano R, Keco-Huerga A, Pabón-Carrasco M, Castro-Fernandez M, Boltin D, Barrio J, Phull P, Kupcinskas J, Jonaitis L, Ortiz-Polo I, Tepes B, Lucendo AJ, Huguet JM, Areia M, Jurecic NB, Denkovski M, Bujanda L, Ramos-San Román J, Cuadrado-Lavín A, Gomez-Camarero J, Jiménez Moreno MA, Lanas A, Martinez-Dominguez SJ, Alfaro E, Marcos-Pinto R, Milivojevic V, Rokkas T, Leja M, Smith S, Tonkić A, Buzás GM, Doulberis M, Venerito M, Lerang F, Bordin DS, Lamy V, Capelle LG, Marlicz W, Dobru D, Gridnyev O, Puig I, Mégraud F, O’Morain C, Gisbert JP; Hp-EuReg Investigators. Empirical rescue treatment of Helicobacter pylori infection in third and subsequent lines: 8-year experience in 2144 patients from the European Registry on H. pylori management (Hp-EuReg). Gut. 2022 Dec 5:gutjnl-2022-328232.
  9. Ellul P, Revés J, Abreu B, Chaparro M, Gisbert JP, Allocca M, Fiorino G, Barberio B, Zingone F, Pisani A, Cassar D, Michalopoulos G, Mantzaris G, Koutroubakis I, Karmiris K, Katsanos K, Ďuricova D, Burisch J, Madsen GR, Maaser C, Arebi N, Orfanoudaki E, Milivojevic V, Buisson A, Avedano L, Leone S, Torres J. Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in Inflammatory Bowel Disease patients: an international web-based survey. J Crohns Colitis. 2022.
  10. Nyssen OP, Bordin D, Tepes B…Milivojevic V… On behalf of the Hp-EuReg Investigators, et al. European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients. Gut. 2021;70:40-54.

 

Citation count:

465 (h index 8 – Google Scholar)

Total number of works from SCI list (SSCI): 30

Cumulative impact factor: 167

Involvement in project implementation:

International: COST Project and Hp-EuReg Project

PHONE

011 7555 000

ADDRESS

Neznanog Junaka 15, 11050 Dedinje